[pending] METHOCARBAMOL (METHOCARBAMOL)
Pending LLM rewrite. Source: FDA_DRUG D-0354-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
Lack of Assurance of Sterility: Media fill with bacterial contamination
The recalled product
- Product
- METHOCARBAMOL (METHOCARBAMOL)
- Brand
- METHOCARBAMOL
- Manufacturer
- Somerset Therapeutics Private Limited
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- NDC 70069-101-25
- A240304
- A240305
- A240320
- A240322
- A240334
- A240335
- A240340
- exp. date 05/2026
- A240342
- A240347
- A240385
- A240391
- exp. date 06/2026
- NDC 70069-101-05
- A240326
UPCs (4)
- 0370069101018
- 0370069101100
- 0370069101254
- 0370069101056
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METHOCARBAMOL
- SevereFDA Class I Recall: Methocarbamol Injection for Particulate Matter
FDA (Drugs) · 2024-04-17
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27